Intracoronary Administration of Microencapsulated HGF in a Reperfused Myocardial Infarction Swine Model

Intracoronary Administration of Microencapsulated HGF in a Reperfused Myocardial Infarction Swine Model

Therapy microencapsulation allows minimally invasive, safe, and effective administration. Hepatocyte growth factor (HGF) has angiogenic, anti-inflammatory, anti-apoptotic, and anti-fibrotic properties. Our objective was to evaluate the cardiac safety and effectiveness of intracoronary (IC) administr...

Full description

Bibliographic Details
Main Authors: Virginia Blanco-Blázquez, Claudia Báez-Díaz, Francisco Miguel Sánchez-Margallo, Irene González-Bueno, Helena Martín, Rebeca Blázquez, Javier G. Casado, Alejandra Usón, Julia Solares, Itziar Palacios, Rob Steendam, Verónica Crisóstomo
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
myocardial infarction
swine model
hepatocyte growth factor
microencapsulation
Online Access:https://www.mdpi.com/2308-3425/10/2/86

Internet

https://www.mdpi.com/2308-3425/10/2/86

Similar Items